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effects observed in lethally irradiated tissue and organs. We
examined the effects of exogenously added superoxide dismutase
on cell survival and angiogenesis in lethally irradiated human
primary umbilical vein endothelial cells. Cell survival was signifi 
cantly improved in superoxide dismutase treated cells; the addition
of superoxide dismutase to cells after irradiation was also effec 
tive for increased survival, as it was before irradiation. Moreover,
treatment of cells with superoxide dismutase enhanced the
phosphorylation of mitogen activated protein/extracellular signal 
regulated kinase/extracellular signal regulated kinases 1 and 2 in
human primary umbilical vein endothelial cells. The addition of
superoxide dismutase to cells after irradiation attenuated the
reduction of angiogenesis by irradiation, and inhibition of the
mitogen activated protein/extracellular signal regulated kinase/
extracellular signal regulated kinases signaling pathway abrogated
the rescue effect of superoxide dismutase. Our results suggest
that superoxide dismutase rescues human primary umbilical vein
endothelial cells from endothelial dysfunction caused by irradia 
tion via a pathway requiring activation of mitogen activated
protein/extracellular signal regulated kinase/extracellular signal
regulated kinases 1 and 2.
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Introduction Damage to blood vessels is one of the most common effects of
therapeutic irradiation or accidental exposure of normal
tissue.(1) Accumulating evidence suggests that the role of vascular
endothelial dysfunction is crucial for the pathogenesis of early and
also delayed irradiation toxicity in organs and tissues, although
there is still debate as to whether vascular endothelial cells have
primary involvement in gastrointestinal syndrome caused by
high-dose irradiation.(2–4) When endothelial cells are exposed to
irradiation, cell death, including apoptosis, and the production of
pro-inflammatory molecules occur, leading to early structural
changes and increased permeability of blood vessels. In addition
to this early response, irradiation also causes slow progressive
changes, including prothrombic and procoagulant effects, and
hypertrophy of the vascular wall, resulting in altered blood flow.(5)
The above experimental data are supported by experiences of
radiation therapy and accidental irradiation exposure. Recent
studies have shown that the cross-talk between endothelial cells and
vascular smooth muscle cells can initiate molecular mechanisms
involved in irradiation-induced vascular damage.(6) Moreover,
studies have reported that many agents, such as lovastatin,
sphingosine-1-phosphate, pentoxifylline, as well as inhibitors of
angiotensin-converting enzyme, are experimentally effective for
the treatment of radiation injury in multiple organs or tissues
including endothelial cells.(7) However, an effective treatment of
irradiation-damaged endothelial cells has not yet been established.
Superoxide dismutases (SODs) are enzymes that catalyze the
conversion of superoxide (O2￿−) to hydrogen peroxide (H2O2)
and act as key cellular defense systems against oxidant stress.
Eukaryotic cells contain three types of SODs. Manganese super-
oxide dismutase (MnSOD) is localized to the matrix of mito-
chondria, and its expression is subjected to intense modulation
by various stimuli including irradiation.(8) Copper/Zinc SOD
(Cu/ZnSOD) is located in cytosol and is constitutively expressed.
Therefore, Cu/ZnSOD is considered to be a house-keeping enzyme.
The third SOD, extracellular SOD (ECSOD), is found in extra-
cellular space and is thought to be important for removing
membrane-related oxidase-generated O2￿−.(9) In spite of these
apparent advantages, however, technical reasons have limited the
use of SOD as a drug like other proteins, even in the laboratory,
and rapid renal clearance, slow extravasation due to the molecular
radius, and charge density are factors affecting the pharmaco-
dynamics and pharmacokinetics of enzymes used as drugs.(10)
Experimental attempts at modifying SOD proteins to improve
these properties have been made, including the delivery of SOD
by liposomes in animals.(11,12) Recently, a synthetic compound
termed Eukarion (EUK) containing SOD, catalase and peroxidase
activities has been shown to mitigate apoptosis of endothelial
cells.(13) In addition, clinical trials of SOD have been carried out,
including for bladder inflammation due to irradiation, and for
successful renal transplantation.(10) However, assessment of SOD
for clinical use has been slow, since the mechanisms of SOD in
mitigation or treatment activity are not yet fully understood in
irradiated tissues and organs.
The central core of Cu/ZnSOD polypeptide is homologous to
ECSOD, which is secreted into the extracellular environment.
Therefore, ECSOD is referred to as extracellular Cu/ZnSOD.(14)
Cu/ZnSOD is quite resistant to physical or chemical denaturation.
We examined the effects of exogenously-added Cu/ZnSOD on cell
growth and angiogenic activity using human umbilical vein
endothelial cells (HUVECs). The mitogen-activated protein kinase
(MAPK) pathway is a key component in the transduction of
signaling leading to cell survival or death; activation of the
mitogen-activated protein/extracellular signal-regulated kinase/
extracellular signal regulated kinases 1 and 2 (MEK/ERK1/2)
pathway is closely linked to irradiation-induced apoptosis in
endothelial cells.(15,16) We also determined whether the activation
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of MEK/ERK1/2 was involved in the mechanism of the Cu/
ZnSOD-mediated effect on irradiated endothelial cells.
Materials and Methods
Cells and cell culture. HUVECs (Cambrex BioScience
Walkersville, Inc., Walkersville, MD) were cultured in the
manufacturer’s growth medium (EGM®-2 Bullet Kit®, Cambrex)
in a humidified atmosphere of 5% CO2 and 95% air at 37°C.
Twenty-four hours before the experiments, HUVECs were sub-
cultured into new plates with fresh EGM-2 medium without
vascular endothelial growth factor (VEGF), fibroblast growth
factor-β, or hydrocortisone. HUVECs were irradiated by Cesium-
137 (137Cs) gammator (model M Gammator, Irradiation Machinery,
Parsippany, NJ) at a dose rate of 8.0 Gy/min on a rotating platform.
Reagents. Superoxide dismutase from bovine erythrocytes,
Cu/Zn type (Cu/Zn SOD), was obtained from Wako Pure Chem.
Ind. (Osaka, Japan). Specific activity was 2100 units/mg protein.
MEK inhibitor PD98059, p38 MAPK inhibitor SB203580,  and
PI3K inhibitor LY294002 were from Calbiochem-Novabiochem
Corp. (San Diego, CA).
Surviving fraction. For the determination of survival after
irradiation, the cell monolayer was irradiated in 25-cm2 culture
flasks in the exponential growth phase, before cells reached 70%
confluence. One culture flask per dose was irradiated with doses
ranging from 1 to 6 Gy. Immediately after irradiation, the cells
were rinsed, trypsinized and seeded in culture dishes at low
density, with 5 replications per dose. After incubation for 13 days,
the colonies were fixed and stained with Giemsa. Colonies of
more than 50 cells were scored as survivors.
Matrigel tube formation assay. MatrigelTM (BD Matrigel
Matrix, BD Biosciences Discovery Labware, Bedford, MA) was
thawed at 4°C, and 50 μl of growth factor-reduced Matrigel was
layered onto each well of a 96-well plate. Matrigel was allowed to
solidify at 37°C for 30 min. HUVECs were irradiated with γ-ray,
treated with trypsin/EDTA after irradiation, and resuspended in
EGM-2 medium at 1 × 105 cells/ml. Fifty micro-liters of the cell
suspension (5000 cells of HUVECs) was seeded onto presolidified
Matrigel of each well, and 50 μl of 2-fold concentrated SOD was
added. After incubation for 16 h, the formation of capillary-like
structures was examined microscopically. Tube-like formation
was scored for each well by counting the number of lumen
structures within four randomly selected view fields of the micro-
scope (40×), and photos were taken.(17) Tube formation in the
presence of SOD and/or irradiation was scored and compared to
tube formation in media alone; the tube-forming capacity of
HUVECs media alone was assumed to be 100%.
Western blot analysis. HUVECs were lysed in ice-cold
buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 3 mM
NaN3, 0.1% (w/v) SOD, 1% (v/v) NP-40 and 0.5% sodium deoxy-
cholate. The protein concentration of each sample was measured.
Fifty micro-grams of protein from the total extract was separated
in 10% SDS polyacrylamide gel. After wet blotting to PVDF and
blocking of non-specific binding (5% dry milk in TBS/Tween 20;
1 h at room temperature), filters were incubated for overnight at
4°C with the corresponding primary antibody diluted to 1:1000 in
5% dry milk in TBS/0.1% Tween 20. After washing and incu-
bating with secondary peroxidase-coupled anti-rabbit or anti-mouse
antibody (1:5000), proteins were visualized by autoradiography
using ECL (Amersham Biosciences, Boston, MA).
Statistical analysis. All values were presented as mean ± SD
or SE as indicated. Data were analyzed using the Student’s t test
(Ekuseru-Tokei® 2003 software, Social Survey Research Informa-
tion Co., Ltd., Tokyo, Japan). Differences were considered signif-
icant at p<0.05.
Results
Improved survival of irradiated HUVECs by Cu/ZnSOD.
To determine the effect of SOD in irradiated HUVECs, clonogenic
survival analysis was performed. Cells were treated with 50 units/
ml of SOD for 1 h and then irradiated at a dose of 0, 1, 2, 4, or 6
Gy. Cells were plated and cultured for 13 days. The clonogenic
survival results after irradiation with γ-rays are shown in Fig. 1.
Plating efficiency was 0.027 ± 0.005 in untreated control cells and
0.027 ± 0.004 SOD-treated cells, showing no statistically signifi-
cant difference. Pretreatment with SOD significantly increased the
survival of these cells irradiated with 1 Gy (p = 0.0109, Table 1).
HUVECs cultured with SOD before irradiation also had signifi-
cantly increased survival fractions as compared to cells without
SOD at higher doses of irradiation (Table 1). Upon irradiation with
6 Gy, survival was 17 times higher in SOD-treated cells compared
to control cells (p = 0.0061).
In parallel, we also studied the effects of SOD treatment after
irradiation on survival fractions in these cells. Cells were irradiated
and 50 units/ml of SOD was added to cell cultures 30 min later.
The addition of SOD after irradiation also increased radiation
resistance significantly at each of the doses used. However,
pre-irradiation SOD-treatment of cells was more effective for
improving survival fractions compared to post-irradiation at a
dose of 4 or 6 Gy. Addition of SOD to cell culture did not affect
the pH level of culture supernatants in the present study (data not
shown).
Effects of Cu/Zn SOD on tube forming capacity in irradiated
HUVECs. Since treatment with SOD even after irradiation
improved the survival rate of these HUVECs, we determined
whether SOD affects angiogenesis in irradiated cells. Endothelial
Fig. 1. Effects of SOD on survival of HUVECs after irradiation. HUVECs
were cultured with 50 units/ml of SOD for 1 h and then irradiated with
γ ray (8 Gy/min) in the presence of SOD (squares, SOD + Irradiation).
In parallel, cells were irradiated and then SOD was added to cell
cultures (triangles, Irradiation + SOD). As control, cells were exposed to
irradiation alone (circles, control). Colonies were stained with Giemsa
13 days after irradiation, and those having over 50 cells were counted.
Results are presented as the mean of 5 separate experiments. Plating
efficiencies of untreated control cells and SOD treated cells were
0.027 ± 0.005 and 0.027 ± 0.004, respectively.doi: 10.3164/jcbn.11 15
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cells plated on Matrigel undergo attachment, migration, and
differentiation events to form interconnected networks of endo-
thelial cell-lined tubes, recapitulating the angiogenic process.(18)
Thus, tube formation is an important mechanism in angiogenesis.
We first examined the effects of SOD on the ability of endothelial
cells to form tubular structures. Cells were cultured with SOD for
16 h (Fig. 2A). The endothelia cells plated on Matrigel formed
abundant networks of branching and organized to lumen-like
structures with multicentric anastomoses. For quantification of
tube formation, the numbers of endotubes were counted in the
microscopic fields (Fig. 2B). When these HUVECs were plated
onto Matrigel covered plates in the presence of SOD, tube
formation was significantly increased. Treatment of cells with as
low as 1 unit/ml SOD resulted in about 40% increase in capability
of tube formation (compared to control: p = 0.0164), with tube
formation reaching a maximum in cells treated with 5 units/ml of
SOD (compared to control: p= 0.0456). The capability of tube
formation was reduced thereafter, and no significant effects on
tube formation capability were observed in cells treated with 50 or
100 units/ml of SOD.
To determine whether SOD could affect tube formation with
radiation, HUVECs were irradiated at a dose of 20 Gy and then
plated onto Matrigel with or without SOD. The numbers of
endotubes were counted after 16 h. Exposure to irradiation with 20
Gy resulted in almost 75% reduction of the capability of tube
formation compared to that of control. On the other hand, SOD
attenuated the reduction of the tube-forming capability by irradia-
tion. Treatment of HUVECs with 5 units/ml of SOD increased the
capability by more than 2-fold compared to that of cells only
irradiated (p = 0.0198). However, there was no significant differ-
ence in the capability of tube formation among the cell groups
receiving 5, 50, and 100 units/ml of SOD, whereas cells treated
with 50 or 100 units/ml of SOD also had a significantly higher
capability than cells exposed to irradiation alone (irradiation alone
vs 50 units/ml: p = 0.0139, irradiation alone vs 100 units/ml:
p = 0.0399).
Role of MEK pathway for rescue effects of SOD on angio 
genesis in irradiated HUVECs. To examine whether the MEK
signal pathway is involved in the rescue effects of SOD on tube
formation, PD98059, an inhibitor of the MEK pathway, was used.
PD98059 is a cell-permeable inhibitor of MEK that inhibits the
activation of MAPK and the subsequent phosphorylation of
MAPK kinase substrates.(19) Cells were cultured with 10 μM of
PD98059 for 1 h and then irradiated with 20 Gy. After irradiation,
cells were plated onto Matrigel including 5 units/ml of SOD
(Table 2). Treatment with PD98059 reduced the effect of SOD on
angiogenesis by 44.1 ± 6.7% in HUVECs (p = 0.0197) cultured
Table 1. p values from comparison of surviving fractions among the three cell groups
Statistical analysis was performed for results presented in Fig. 1 and Table 1 as described in “Materials and
Methods”. ns: not significant.
Dose (Gy) Control vs Before SOD Control vs After SOD Before  vs After SOD
1 0.0109 0.0017 0.1027 (ns)
2 0.0013 0.0005 0.1810 (ns)
4 0.0003 0.0007 0.0031
6 0.0061 0.0019 0.0237
Fig. 2. Effects of SOD on tube formation in irradiated HUVECs. HUVECs were irradiated with 20 Gy and then cultured on Matrigel® without (con 
trol) or with 5 units/ml of SOD for 16 h. For quantification of tube formation, the number of endotubes was counted in each microscopic field, and
data from 4 fields of each well were analyzed. The number of endotubes in control was assumed to have 100% activity. Data represent mean ± SE
from 3 experiments. (A) Representative photographs of capillary like tube structures on Matrigel. (B) Quantification of numbers of endotubes in
irradiated HUVECs. *p = 0.0164, **p = 0.0456,***p = 0.0198, ****p = 0.0139, *****p = 0.0399.
Table 2. Effect of MEK/ERK pathway inhibition on angiogenesis by SOD
in irradiated HUVECS
Cells were cultured with 10 μM of PD98059 for 1 h and then irradiated
with 20 Gy. After irradiation, cells were plated onto Matrigel including
5 units/ml of SOD. Experiments were triplicated and results were ex 
pressed as percentage tube forming capacity of untreated control cells.
*p = 0.0079, **ns, ***p = 0.0084, ****p = 0.0197.
(%)
Untreated control 100.0 ± 25.8*,**
Irradiation 38.7 ± 5.6*,***
PD98509 95.7 ± 9.7**
Irradiation + SOD 65.6 ± 10.4***,****
PD + Irradiation + SOD 44.1 ± 6.7**** J. Clin. Biochem. Nutr. | January 2012 | vol. 50 | no. 1 | 81
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with 5 units/ml of SOD after irradiation, whereas treatment with
PD98059 alone failed to affect the capacity significantly as com-
pared to untreated control. We also used highly specific inhibitors
of p38MAPK (SB203580) and PI3K (LY294002). SB203580 is a
highly selective inhibitor of p38 MAPK that acts by competitively
inhibiting ATP binding.(20) LY294002 specifically inhibits PI3K
activity via competitive inhibition of the ATP-binding site located
on the p85α subunit of PI3K.(21) However, these inhibitors did not
affect the tube-forming capacity in irradiated HUVECs (data not
shown).
To further study the involvement of the MEK pathway in the
tube-forming capacity of irradiated cells, western blot analysis
was performed using an antibody against phosphorylation of
ERK. HUVECs were irradiated with 20 Gy and harvested at
different durations (Fig. 3A). A time-course study showed that
the levels of phosphorylated ERK were increased by irradiation,
reaching a plateau 4 h after irradiation and then gradually
decreasing. Cells were also cultured with 5 or 50 units/ml of SOD
for different durations (Fig. 3 B and C). We found that SOD
markedly increased the levels of phosphorylated ERK at 2 h, and
at 6 h they had returned close to baseline. However, significant
activation of ERK was not observed 0.5 or 1 h after exposure or
the addition of SOD to cells (data not shown).
In a parallel study, SOD was added to HUVECs either 1 h
before or 30 min after irradiation with 20 Gy (Fig. 3D). Cells
were then cultured for 4 h and harvested for western blot analysis.
Cells treated with SOD after irradiation had almost the same or
increased level of the phosphorylated form of ERK compared to
that of cells treated with SOD or irradiation alone. Moreover,
treatment with PD98059 significantly inhibited phosphorylation
of ERK by either irradiation, SOD, or the combinations with SOD
and irradiation in these cells.
Discussion
Endothelial cells are one of the most critical targets for the
pathologic effects of irradiation in vivo, and it is known that the
vascular endothelium within tissues and organs including lung,
brain, and skin is the actual target of radiation damage. Thus,
vascular damage is a key mechanism in tissue and organ injuries
caused by irradiation. In the present study, we found that
exogenously-added Cu/ZnSOD effectively protected and also
rescued HUVECs from lethal irradiation, and stimulated angio-
genesis in these cells. Furthermore, this effect occurred through a
pathway requiring activation of MEK. There are many reports of
agents with radioprotective capability. The administration of
agents to reduce either the incidence or severity of radiation-
induced normal tissue injury is called mitigation or treatment.(7)
However, most of these radioprotective agents are effective only
when they are added to cells or administered to experimental
animals before irradiation, and the mechanistic basis of mitigation
or treatment agents for the experimental successes has not been
Fig. 3. Effects of SOD on phosphorylation of ERK1/2 in irradiated HUVECs. (A) Effects of irradiation on phosphorylated ERK1/2. HUVECs were
irradiated with 20 Gy and cultured for different durations. Cells were sequentially harvested at indicated times and subjected to western blot
analysis using anti ERK1/2 (ERK) or phospholylated ERK1/2 (p ERK1/2) antibody. Levels of β actin were used as loading control. (B) and (C) Effects of
SOD on phosphorylated ERK1/2. Cells were treated with either 5 or 50 units/ml of SOD. Levels of phospholylated form of ERK1/2 were determined
by western blotting. (D) Effects of SOD treatment either before or after irradiation on phosphorylation of ERK1/2 in irradiation. HUVECs were
pre treated with SOD (50 units/ml) for 1 h and then irradiated with 20 Gy in the presence of SOD (SOD + Irradiation), or they were irradiated and
then SOD was added to cell cultures 30 min later (Irradiation + SOD). After culturing with SOD for 4 h, both groups of cells were subjected to
western blot analysis. For inhibition of the MEK pathway, cells were treated with 50 μM of PD98059 for 30 min and then irradiated and/or treated
with SOD.doi: 10.3164/jcbn.11 15
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established. It is noteworthy that, for the prevention of angio-
genesis inhibition from irradiation, the addition of SOD to cells
after irradiation is also effective. Thus, the present data suggest the
possibility of Cu/ZnSOD as a therapeutic agent for the treatment
of blood vessel injuries by irradiation, providing insight into how
Cu/ZnSOD mediates angiogenesis in irradiated endothelial cells.
Endothelial cells constitutively produce reactive oxygen species
(ROS) and are known to have a very high sensitivity to ROS. This
production is augmented by exposure of cells to extra-cellular
sources of ROS such as irradiation as well as hypoxia and
ischemia.(22,23) On the other hand, ROS play an important role in
angiogenesis in endothelial cells.(24) Many angiogenic responses
are mediated through ROS in endothelial cells; angiogenic factors
such as VEGF, a major angiogenesis factor, and also angio-
poietin-1 (Ang1), are induced through an increase in ROS, and
these factors stimulate proliferation and angiogenesis in these
cells. Recent studies have shown that endothelial cells over-
expressing either MnSOD or Cu/ZnSOD had a higher angiogenic
potential dependent on the generation of H2O2.(25,26) The activity of
Cu/ZnSOD depends on copper for its enzymatic activity. Inhibi-
tion of Cu/ZnSOD by binding or chelating copper ion decreases
angiogenesis, and diet-related depletion of copper has also been
shown to inhibit angiogenesis.(26–28) Thus, SODs, especially Cu/
ZnSOD, are important for angiogenesis. In the present study, the
addition of low concentrations of Cu/ZnSOD stimulated angio-
genesis in control as well as in irradiated cells. Cu/ZnSOD added
exogenously to cell culture is known to be incorporated into
cells, as prior study has shown that exogenously-added Cu/ZnSOD
penetrates the cellular membrane and increases total SOD
activity.(29) Further studies reported that exogenously-added Cu/
ZnSOD induced neutrophil apoptosis via accumulation of H2O2,(30)
and effectively blocked monocytic differentiation of leukemic
cells with platelet-activating factor (PAF)(31) and stimulation of
neonatal rat hepatocyte growth by tumor promoters.(32) On the
other hand, SOD activity is observed in the circulatory system of
mammalian cells. ECSOD is a secreted enzyme that requires
copper and zinc for enzymatic activity.(33) The ECSOD gene is
about 60% homologous with Cu/ZnSOD, especially in the region
of active sites, but no similarity with MnSOD was observed.(33)
The central core of ECSOD polypeptide is homologous with
Cu/ZnSOD but possesses extensions at the N- and C-termini.(34)
Human ECSOD is related to dimeric Cu/ZnSOD, which is typically
produced in vascular smooth muscle cells, and is secreted into
the extracellular environment where it binds to the extracellular
matrix and endothelial surface components.(14) Thus, Cu/ZnSOD
is structurally similar to ECSOD. In contrast, MnSOD is located
in the matrix of mitochondria in eukaryotes, and mitochondrial
localization is required for protection of cells by MnSOD from
irradiation damage.(35) There is no similarity in sequence or
structure between Cu/ZnSOD and MnSOD. Exogenously-added
Cu/ZnSOD may act in a way similar to ECSOD, whereas an
alternative mechanism may involve the suppression of O2￿−
generating systems such as NADPH oxidase by extracellular Cu/
ZnSOD.(32)
It has been reported that basic fibroblast growth factor (bFGF)
and vascular VEGF trigger angiogenic response through a pathway
requiring activation of the MEK/ERK pathway,(36) and inhibition
of this pathway is known to lead to reduced angiogenesis.(27)
Recent studies have also revealed that the MEK/ERK pathway is
closely linked to irradiation-induced apoptosis in endothelial cells;
bFGF and VEGF have been known to protect these cells from
radiation-induced cell death via the MEK/ERK pathway.(15,16)
Thus, activation of the MEK/ERK pathway is a key event for cell
function and survival in irradiated endothelial cells. In the present
study, treatment with SOD increased cell survival without affecting
plating efficiency and stimulated angiogenesis with concomitant
activation of ERK1/2 phosphorylation in irradiated HUVECs, and
inhibition of the MEK/ERK pathway abrogated the effect of SOD
in these cells. These results suggest that activation of the MEK/
ERK pathway is closely related to the rescue effect of Cu/ZnSOD
on damage caused by irradiation. Our study also shows that the
rescue effects of SOD may act through a different mechanism
from those of VEGF and bFGF, since these growth factors
are known to increase plating efficiency of endothelial cells.(37)
Recently, it has become more evident that H2O2 serves an
important regulatory role in cell growth/proliferation and signaling
pathways.(38,39) Furthermore, H2O2 has been shown to regulate pro-
angiogenic responses in a variety of systems.(25) The accumulation
of H2O2 by SOD may trigger the activation of the ERK pathway,
leading to the rescue effect in irradiated cells. Moreover, treatment
of cells with SOD after lethal irradiation effectively rescued these
cells and also increased the capability of tube formation. We also
found that the level of the phosphorylated form of ERK1/2 was
increased in cells treated with SOD even after irradiation. Recent
studies have shown that irradiated cells can exhibit persistent and
prolonged generation of ROS that can last from minutes to
days.(40–42) NADPH oxidases are the primary physiological ROS
producers, and O2￿− is the first member of ROS generated by
NADPH oxidase.(43) Detoxifying the prolonged generation of O2￿−
as well as shorter generation may contribute to the rescue effect of
SOD in irradiated endothelial cells.
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Ang1 angiogenesis factor, and also angiotpoietin-1
Cu/ZnSOD Copper/Zinc SOD
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